Literature DB >> 8089475

CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity.

M Alzona1, H M Jäck, R I Fisher, T M Ellis.   

Abstract

CD30 is a lymphoid activation Ag expressed by activated B and T lymphocytes, as well as selected lymphoid malignancies. In T cells, CD30 expression is limited to a minority (15 to 25%) of activated CD45RO+ T cells. Studies were undertaken to define unique functional properties of CD30+ T cells by identifying the profile of cytokine production by CD30+ T cells, and by assessing their ability to provide help for B cell Ig production. Assessment of cytokine mRNA transcripts by reverse transcription-PCR (RT-PCR) revealed the presence of IFN-gamma mRNA transcripts only in CD30+ T cells derived from FACS purified from activated CD45RO+ T cells. IFN-gamma mRNA was present neither in the CD30- subset of activated CD45RO+ T cells, nor in activated CD45RA+ T cells. Both CD30+ and CD30- subsets expressed IL-10 and IL-2R alpha mRNAs after 3 days of activation, but neither population expressed IL-4 or IL-6 transcripts at this time. Furthermore, production of secreted IFN-gamma was significantly greater in activated CD30+CD45RO+ cells (564 +/- 250 pg/ml) than in CD30-CD45RO+ (50 +/- 33 pg/ml) or CD45RA+ (0 +/- 0) T cells. CD30+ T cells also expressed IL-5 mRNA and secreted significantly higher levels of IL-5 (320 +/- 73) than activated CD30-CD45RO+ (17 +/- 5) T cells. In contrast, CD30- T cells produced significantly higher levels of IL-2 than CD30+ T cells (1270 +/- 380 vs 450 +/- 128). Induction of IFN-gamma in CD30+ T cells was not a result of CD30 engagement by Abs used during the isolation process, although an anti-CD30 Ab (M44) known to exert agonist activity was capable of inducing IFN-gamma production by T cells when immobilized to plastic. Finally, CD30+CD4+ T cells exhibit significantly greater helper activity for B cell Ig production than CD30-CD4+ T cells. These results demonstrate that CD30 identifies a unique subset of T cells that comprise the major IFN-gamma- and IL-5-producing cells in the T cell compartment, and exhibit potent helper activity for B cell Ig production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089475

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The effect of IL-18 on IL-12-induced CD30 expression and IL-4 and IFN-gamma production by allergen and PPD specific T cells.

Authors:  M Tarkowski; S Chrul; J Bodalski
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Expression of CD30 in patients with acute graft-versus-host disease.

Authors:  Yi-Bin Chen; Sean McDonough; Robert Hasserjian; Heidi Chen; Erin Coughlin; Christina Illiano; In Sun Park; Madan Jagasia; Thomas R Spitzer; Corey S Cutler; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2012-06-01       Impact factor: 22.113

3.  Utilizing IL-12, IL-15 and IL-7 as Mucosal Vaccine Adjuvants.

Authors:  Liljana Stevceva; Marcin Moniuszko; Maria Grazia Ferrari
Journal:  Lett Drug Des Discov       Date:  2006       Impact factor: 1.150

4.  CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.

Authors:  E N Tsitsikov; D A Wright; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD).

Authors:  R Giacomelli; A Passacantando; I Parzanese; P Vernia; N Klidara; F Cucinelli; R Lattanzio; E Santori; P Cipriani; R Caprilli; G Tonietti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 6.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Functional characterization of T cells in abdominal aortic aneurysms.

Authors:  Nerys D Forester; Sheena M Cruickshank; D Julian A Scott; Simon R Carding
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

8.  CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

Authors:  H J Gruss; A Pinto; A Gloghini; E Wehnes; B Wright; N Boiani; D Aldinucci; V Gattei; V Zagonel; C A Smith; M E Kadin; C von Schilling; R G Goodwin; F Herrmann; A Carbone
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

9.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

Review 10.  Hodgkin's lymphoma and CD30 signal transduction.

Authors:  Ryouichi Horie; Masaaki Higashihara; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.